Schizophrenia is a severe and often highly debilitating psychiatric disorder characterized by distorted emotions, thinking ...

For the first time in decades, the Food and Drug Administration has approved a new type of drug for schizophrenia. The twice-a-day pill to be marketed by Bristol Myers Squibb will be called Cobenfy, ...

A new study published in Psychiatry Research provides evidence that certain brain cells are physically smaller in individuals with schizophrenia and that this size difference is related to the ...

A team of researchers has conducted the largest and most comprehensive genome-wide association study (GWAS) to date of ...